These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 8410413)

  • 1. Postmenopausal hormone replacement: are two hormones better than one?
    Wood H; Wang-Cheng R; Nattinger AB
    J Gen Intern Med; 1993 Aug; 8(8):451-8. PubMed ID: 8410413
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic controversy: Estrogen replacement in menopause.
    Lindsay R; Bush TL; Grady D; Speroff L; Lobo RA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3829-38. PubMed ID: 8923821
    [No Abstract]   [Full Text] [Related]  

  • 3. Estrogen replacement therapy in women: prevention and treatment of coronary artery disease.
    Valle BK; Lemberg L
    Am J Crit Care; 1994 Sep; 3(5):398-401. PubMed ID: 8000465
    [No Abstract]   [Full Text] [Related]  

  • 4. Recent studies bring risks, benefits of hormone replacement therapy under scrutiny.
    Friedrich MJ
    J Natl Cancer Inst; 2001 Sep; 93(17):1287-8. PubMed ID: 11535698
    [No Abstract]   [Full Text] [Related]  

  • 5. Summaries for patients. Postmenopausal hormone replacement therapy to prevent chronic conditions: recommendations from the U.S. Preventive Services Task Force.
    U.S. Preventive Services Task Force
    Ann Intern Med; 2002 Nov; 137(10):I48. PubMed ID: 12435233
    [No Abstract]   [Full Text] [Related]  

  • 6. What pharmacists need to know about the women's health initiative estrogen plus progestin trial.
    Saseen JJ; Hansen LB
    Am J Health Syst Pharm; 2003 Feb; 60(3):281-4. PubMed ID: 12613239
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hormone therapy in climacteric. Different effects of estrogen and gestagen on the risk of breast and endometrial cancer].
    Magnusson C; Weiderpass E
    Lakartidningen; 2001 Jan; 98(5):418-21. PubMed ID: 11229082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial cancer and hormone-replacement therapy in the Million Women Study.
    Beral V; Bull D; Reeves G;
    Lancet; 2005 Apr 30-May 6; 365(9470):1543-51. PubMed ID: 15866308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy should not be used as secondary prevention of coronary heart disease.
    Barbour MM
    Pharmacotherapy; 2000 Sep; 20(9):1021-7. PubMed ID: 10999492
    [No Abstract]   [Full Text] [Related]  

  • 10. Hormone replacement therapy and endometrial cancer.
    Emons G; Huschmand-Nia A; Krauss T; Hinney B
    Onkologie; 2004 Apr; 27(2):207-10. PubMed ID: 15138357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women.
    Beresford SA; Weiss NS; Voigt LF; McKnight B
    Lancet; 1997 Feb; 349(9050):458-61. PubMed ID: 9040575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications of hormone replacement therapy in post-menopausal women.
    Studd J
    J R Soc Med; 1992 Jul; 85(7):376-8. PubMed ID: 1629843
    [No Abstract]   [Full Text] [Related]  

  • 13. Hormone replacement therapy (HRT)--risks and benefits.
    Barrett-Connor E; Stuenkel CA
    Int J Epidemiol; 2001 Jun; 30(3):423-6. PubMed ID: 11416055
    [No Abstract]   [Full Text] [Related]  

  • 14. Weighing the risks and benefits of hormone therapy.
    Toth S; Blanchard E; Herman L; Larson L; Léger MM; McNellis R; Quigley T; Van Dyke E
    JAAPA; 2003 Jun; 16(6):45-7. PubMed ID: 14968505
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical practice. Postmenopausal hormone-replacement therapy.
    Manson JE; Martin KA
    N Engl J Med; 2001 Jul; 345(1):34-40. PubMed ID: 11439947
    [No Abstract]   [Full Text] [Related]  

  • 16. Postmenopausal hormone replacement therapy.
    Jacobs HS; Loeffler FE
    BMJ; 1992 Dec; 305(6866):1403-8. PubMed ID: 1343093
    [No Abstract]   [Full Text] [Related]  

  • 17. Balancing between observational studies and randomized trials in prevention of coronary heart disease by estrogen replacement: HERS study was no revolution.
    Ylikorkala O
    Acta Obstet Gynecol Scand; 2000 Dec; 79(12):1029-36. PubMed ID: 11130082
    [No Abstract]   [Full Text] [Related]  

  • 18. [Current status: hormone substitution and risk of endometrial carcinoma].
    Kuhl H
    Zentralbl Gynakol; 1997; 119(6):296-7. PubMed ID: 9312968
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term postmenopausal hormone therapy and endometrial cancer risk: a study by Doherty et al.
    Odem RR; Moniz MH; Allsworth JE; Bleckman CR; Omicioli VA; Lawrence LT; Thaker PH
    Am J Obstet Gynecol; 2007 Aug; 197(2):213-4; discussion e1-5. PubMed ID: 17689656
    [No Abstract]   [Full Text] [Related]  

  • 20. Hormone replacement therapy. Clinical synthesis panel on HRT.
    J Epidemiol Biostat; 1999; 4(3):123-8. PubMed ID: 10695954
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.